Sharon Hutchinson

Has grant

Professor of Epidemiology and Population Health

Glasgow Caledonian University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sharon Hutchinson is a Professor of Epidemiology and Population Health at Glasgow Caledonian University, UK. Her research focuses on the public health implications of drug use, including the prevalence of Hepatitis C among people who inject drugs, the risks associated with non-prescribed benzodiazepine use, and the impact of opioid-agonist treatment during the COVID-19 pandemic. Recent publications highlight the critical issues of drug-related mortality, treatment outcomes, and monitoring infectious diseases within this vulnerable population.

Recent Grants

Grant: Close

Evaluating Population Impact of hepatitis C DAA Treatment as Prevention to people who inject drugs (EPIToPe)

Open Date: 2019-02-01

Close Date: 2024-07-01

Grant: Close

Incidence, prevalence, harms and intervention effects for problem and injecting drug use: crime, morbidity & mortality

Open Date: 2011-02-14

Close Date: 2014-12-13

Grant: Close

Record-linkage study to determine the hospital utilisation, morbidity and mortality related to diagnosed HCV infection and association between alcohol and diagnosed HCV infection among injectors in Scotland.

Open Date:

Close Date:

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (17)

Sofia Bartlett

Adjunct Professor

The University of British Columbia

CANADA

Sharon Hutchinson

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Post‐treatment life‐trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis

Risk of drug-related mortality among people receiving opioid-agonist treatment during the COVID-19 pandemic in Scotland

Rising mortality among people who inject drugs living with HIV in Scotland, UK: A 20-year retrospective cohort study

Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study

Examining trends in the incidence of HIV infection among people with a history of drug use to inform an outbreak investigation and response: a retrospective cohort study

A novel, multi-component contingency management intervention in the context of a syndemic of drug-related harms in Glasgow, Scotland: first year of the ‘WAND’ initiative

Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

Standardising monitoring data on drug-related infectious diseases among people who inject drugs in Europe – an update of the European Union Drugs Agency technical protocol, 2024

Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Improved health‐related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable

Laying the foundations for hepatitis C elimination

Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe

A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data

Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study

Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK.

Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study.

Securing wider EU commitment to the elimination of hepatitis C virus.

Collaborators (17)

Sofia Bartlett

Peter Vickerman

John Dillon

jack Stone

Andrew Radley

ANGELOS HATZAKIS

Alan Yeung

Norah Palmateer

Magdalena Harris

Eva Emanuel

Steffanie Strathdee

Matthew Hickman

Paul Flowers

Andrew McAuley

Chris Byrne

Peter Jarcuska

Daniela De Angelis

Make your next move.